Novel molecular approaches toward therapy of chronic hepatitis B

Archives of Virology

Volumn 142, Issue 3, 1997, Pages 611-628

  Nassal, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL; ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

ANIMALS; BASE SEQUENCE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

ANIMALIA; HEPATITIS B VIRUS;

EID: 0030935490     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050107     Document Type: Article

References (80)

1. Abdel-Meguid SS, Metcalf BW, Carr TJ, Demarsh P, DesJarlais RL, Fisher S, Green DW, Ivanoff L, Lambert DM, Murthy KH (1994) An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis. Biochemistry 33: 11671-11677
2. Altman S (1995) R Nasc P in research and therapy. Bio Technology 13:327-329
3. Baker B, Muckenthaler M, Vives E, Blanchard A, Braddock M, Nacken W, Kingsman AJ, Kingsman SM (1994) Identification of a novel HIV-1 TAR RNA bulge binding protein. Nucleic Acids Res 22:3365-3372
4. Beck J, Nassal M (1995) Efficient cleavage of the structured hepatitis B virusRNA encapsidation signal in vitro and in cell extracts but not in intact cells. Nucleic Acids Res 23
5. Bianchi E, Folgori A, Wallace A, Nicotra M, Acali S, Phalipon A, Barbato G, Bazzo R, Cortese R, Felici F, Pessi A (1995) A conformationally homogeneous combinatorial peptide library. J Mol Biol 247: 154-160
6. Biocca S, Pieranddrie-Amaldi P, Campioni N, Cattaneo A (1994) Intracellular immunization with cytosolic recombinant antibodies. Bio Technology 12: 396-399
7. Boffa LC, Carpaneto EM, Allfrey VG (1995) Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid. Proc. Natl Acad Sci USA 92: 1901-1905
8. Bonhoeffer S, Holmes EC, Nowak MA (1995) Causes of HIV diversity. Nature 376: 125
9. Chang C, Zhou S, Ganem D, Standring DN (1994) Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential J Virol 68: 5225-5231
10. Chisari FV (1995) Hepatitis B virus transgenic mice: Insights into the virus and the disease. Hepatology 22: 1316-1325
11. Civitico GM, Locarnini SA (1994) The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 203: 81-89
12. Condra JH, Schleif WA, Blahy OM, Gabryelski LJ, Graham DJ, Quintero JC, Rhodes A, Robbins HL, Roth E, Shivaprakash M, Titus D, Yang T, Teppler H, Squires KE, Deutsch PJ, Emini EA (1995) In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374: 569-571
13. Crowther RA, Kiselev NA, Böttcher B, Berriman JA, Borisova GP, Ose V, Pumpens P (1994) Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77: 943-950
14. Dean PM (1994) Recent advances in drug design methods: where will they lead? Bioessays 16: 683-687
15. Dropulic B, Jeang KT (1994) Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Hum Gene Ther 5: 927-939
16. Dyson MR, Murray, K (1995) Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci USA 92: 2194-2198
17. Fields S, Sternglanz, R (1994) The two-hybrid system: an assay for protein-protein interactions. Trends Genet 10: 286-292
18. Gait MJ, Karn J (1995) Progress in anti-HIV structure-based drug design. Trends Biotech 13: 430-438
19. Giovannangeli C, Thuong NT, Helene, C (1993) Oligonucleotide clamps arrest DNA synthesis on a single-stranded DNA target. Proc Natl Acad Sci USA 90: 10013-10017
20. Gold L, Tuerk C, Allen P, Binkley J, Brown D, Green L, MacDougal S, Schneider D, Tasset D, Eddy SR (1993) In: Gesteland RF, Atkins JF (eds) The RNA world. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 497-510
21. Hasselof J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585-591
22. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126
23. Houghten RA (1993) Peptide libraries: criteria and trends. Trends Genet 9:235-239
24. Junker-Niepmann M, Bartenschlager R, Schaller H (1990) A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 9: 3389-3396
25. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR (1994) A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 75: 443-448
26. Kenney JM, von Bonsdorff C-H, Nassal M, Fuller SD (1995) Conformational flexibility and evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure 3: 1009-1019
27. Kiehntopf M, Esquivel EL, Brach MA, Hermann F (1995) Clinical applications of ribozymes. Lancet 345: 1027-1031
28. Klingmüller U, Schaller H (1993) Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol 67: 7414-7422
29. Knaus T, Nassal M (1993) The encapsidation signal on the hepatitis B virus RNA Pregenome forms a stem-loop structure that is critical for its function. Nucleic Acids Res 21: 3967-3975
30. Laskus T, Rakela J, Persing DH (1994) The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology 200: 809-812
31. Landford R E, Notvall L, Beames B (1995) Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J Virol 69: 4431-4439
32. Larder BA, Kemp SD, Harrigan PR (1995) Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 269: 696-699
33. Lau JYN, Wright TL (1993) Molecular virology and pathogenesis of hepatitis B. Lancet 343: 1335-1340
34. Lee SW, Gallardo HF, Gilboa E, Smith C (1994) Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J Virol 68: 8254-8264
35. Lisziewicz J. Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci USA 90: 8000-8004
36. Lok ASF, Akarca U, Greene S (1994) Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 91: 4077-4081
37. Lok ASF (1994) Treatment of chronic hepatitis B. J. Viral Hepatitis 1: 105-124
38. Macilwain C (1994) Fialuridine: US health agencies at odds over trial deaths. Nature 369: 433
39. Mason WS, Seeger C (eds) Hepadnaviruses. Curr Topics Microbiol Immunol 168
40. McLachlan A (1991) Molecular biology of the hepatitis B virus. CRC Press, Boca Raton
41. Mitsuya H, Yarchoan R, Kageyama S, Broder S (1991) Targeted therapy of human immunodeficiency virus-related disease. FASEB J 5: 2369-2381
42. Nassal M (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107-4116
43. Nassal M, Rieger A, Steinau O (1992) Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking. J Mol Biol 225: 1013-1025
44. Nassal M, Schaller H (1993) Hepatitis B virus replication. Trends Microbiol 1: 221-226
45. Nassal M, Schaller H (1993) Hepatitis B virus nucleocapsid assembly. In: Dörfler W, Böhm P (eds) Virus strategies. VCH, Weinheim, pp 41-75
46. Nassal M (1996) Hepatitis B virus morphogenesis. Curr Topics Microbiol Immunol 214: 297-337
47. 46a. Nassal M, Rieger A (1996) A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand synthesis. J Virol 70: 2764-2773
48. Natsoulis G, Boeke JD (1991) New antiviral strategy using capsid-nuclease fusion proteins. Nature 352: 632-635
49. Natsoulis G, Seshaiah P, Federspiel MJ, Rein A, Hughes SH, Boeke JD (1995) Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci USA 92: 364-368
50. Nellen W, Lichtenstein C (1993) What makes an mRNA anti-sense-itive? Trends Biochem Sci 18: 419-423
51. Neurath AR, Kent SBH, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46: 429-436
52. Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497-1500
53. Offensperger WB, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE, Gerok W (1993) In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 12: 1257-1262
54. Osuna J, Flores H, Soberon X (1994) Microbial systems and directed evolution of protein activities. Crit Rev Microbiol 20: 107-116
55. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K (1979) Hepatitis B virus genes and their expression in E. coli. Nature 282: 575-579
56. Peisach E, Casebier D, Gallion SL, Furth P, Petsko GA, Hogan JC, Ringe D (1995) Interaction of a peptidomimetic aminimide inhibitor with elastase. Science 269: 66-69
57. Pollack JR, Ganem D (1993) An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation J Virol 67: 3254-3263
58. Pushko P, Sällberg M, Borisova G, Ruden U, Bichko V, Wahren B, Pumpens P, Magnius L (1994) Identification of hepatitis B virus core protein regions exposed or internalized at the surface of H BcAg particles by scanning with monoclonal antibodies. Virology 202: 912-920
59. Richardson JH, Marasco WA (1995) Intracellular antibodies: development and therapeutic potential. Trends Biotech 13: 306-310
60. Rieger A, Nassal M (1995) Distinct requirements for primary sequence in the 5′- and 3′-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combined in vivo selection/in vitro amplification system. Nucleic Acids Res 23: 3909-3915
61. Scaglioni PP, Melegari M, Wands JR (1994) Characterization of hepatitis B virus core mutants that inhibit viral replication. Virology 205: 112-120
62. Schirmbeck R, Böhm W, Ando K, Chisari FV, Reimann J (1995) Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 69: 5929-5934
63. Schödel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR (1992) The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 66: 106-114
64. Schödel F, Peterson D, Hughes J, Milich DR (1994) Hepatitis B virus core particles as a vaccine carrier moiety. Int Rev Immunol 11: 153-165
65. Sczakiel G, Nedbal W (1995) The potential of ribozymes as antiviral agents. Trends Microbiol 3: 213-217
66. Seifer M, Slandring DN (1994) A protease-sensitive hinge linking the two domains of the hepatitis B virus core protein is exposed on the viral capsid surface. J Virol 68: 5548-5555
67. Seifer M, Standring DN (1995) Assembly and antigenicity of hepatitis B virus core particles. Intervirology 38: 47-62
68. Summers J, Mason WS (1982) Replication of the genome of hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403-415
69. Szostak JW, Ellington AD (1993) In: Gesteland RF, Atkins JF (eds) The RNA world. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 511-534
70. Tavis JE, Ganem D (1993) Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc Natl Acad Sci USA 90: 4107-4111
71. Wands JR, Blum HE (1991) Primary hepatocellular carcinoma. N Engl J Med 325: 729-731
72. Wang GH, Seeger C (1992) The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71: 663-670
73. Wang GH, Seeger C (1993) Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 67: 6507-6512
74. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122
75. von Weizäcker F, Blum HE, Wands JR (1992) Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochim. Biophys Res Commun 189: 743-748
76. Wittung P, Nielsen PE, Buchardt O, Egholm M, Norden B (1994) DNA-like double helix formed by peptide nucleic acid. Nature 368: 561-563
77. Yang M, Wu Z, Fields S (1995) Protein-peptide interactions analyzed with the yeast two hybrid system. Nucleic Acids Res 23: 1152-1156
78. Yarchoan R, Mitsuya H, Broder S (1993) Challenges in the therapy of HIV infection. Trends Pharmacol Sci 14: 196-202
79. Yu M, Summers J (1991) A domain of the hepadnavirus capsid protein is specifically required for DNA maturation and virus assembly. J Virol 65: 2511-2517
80. Zhou S, Standring DN (1992) Hepatitis B virus capsid particles are assembled from core-protein dimer precursors. Proc Natl Acad Sci USA 89: 10046-10050